Nisa Investment Advisors’s Ventyx Biosciences VTYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-481
Closed -$4.34K 3127
2025
Q4
$4.34K Hold
481
﹤0.01% 2477
2025
Q3
$1.5K Hold
481
﹤0.01% 2672
2025
Q2
$1.03K Sell
481
-532
-53% -$859 ﹤0.01% 2731
2025
Q1
$1.17K Buy
1,013
+447
+79% +$767 ﹤0.01% 2600
2024
Q4
$1.24K Buy
566
+503
+798% +$1.14K ﹤0.01% 2623
2024
Q3
$137 Sell
63
-230
-78% -$529 ﹤0.01% 2888
2024
Q2
$677 Buy
293
+240
+453% +$997 ﹤0.01% 2615
2024
Q1
$292 Buy
+53
New +$242 ﹤0.01% 2588
2023
Q4
Sell
-721
Closed -$25K 2754
2023
Q3
$25K Hold
721
﹤0.01% 1943
2023
Q2
$23.6K Buy
721
+703
+3,906% +$24.2K ﹤0.01% 2041
2023
Q1
$1K Hold
18
﹤0.01% 2478
2022
Q4
$1K Hold
18
﹤0.01% 2530
2022
Q3
$0 Buy
+18
New +$399 ﹤0.01% 2642

Other funds holding VTYX

Nisa Investment Advisors's VTYX Position: Q1 2026 in Review

Nisa Investment Advisors sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 481 shares — an estimated $4.34K sold.

Nisa Investment Advisors first reported a position in VTYX in Q3 2022 and held it in 13 quarters. The position peaked at $25K in Q3 2023. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • Nisa Investment Advisors reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • Nisa Investment Advisors sold 481 Ventyx Biosciences shares in Q1 2026, an estimated $4.34K.
  • Nisa Investment Advisors first reported a position in Ventyx Biosciences in Q3 2022 and held it in 13 quarters.
  • Nisa Investment Advisors's Ventyx Biosciences position peaked at $25K in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.